openPR Logo
Press release

Overweight Treatment is predicted to reach a market value of US$ 75.1 Bn by 2032|Key Players- Novo Nordisk A/S, VIVUS LLC and more

05-18-2022 07:57 PM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Overweight Treatment Market 2022

Overweight Treatment Market 2022

Overweight Treatment Market 2022

The global Overweight Treatment Market is expected to reach US$ 75.1 Bn by the year 2032 at a CAGR of 7.9%. Healthcare systems have been basically emphasizing on affordability as well as quality of the medical services. However, now, digitization has come through, which would drive revolution in the same healthcare vertical. The life sciences would go digitally innovative. This would be the way healthcare vertical would go in the next 10 years.

Click Here to Get Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/33086

The overweight treatment market is beginning to take hold across the globe with rising number of investments toward various treatment options. According to Persistence Market Research's latest industry analysis, the global overweight treatment market is valued at around US$ 35.2 Bn, and is expected to exhibit a high CAGR of 7.9% over the forecast period (2022-2032).

Weight management methods and treatments are projected to become more popular as out-of-pocket healthcare costs rise in both, emerging and established economies. Per capita healthcare spending is on the rise, which is predicted to fuel the demand for high-quality patient care treatment alternatives. Developing economies such as Brazil, India, and Russia are expected to contribute significantly to the anti-obesity drug development industry.

It has been inferred through various studies that food consumption is directly proportional to the socio-economic status of individuals. The worldwide shift from a predominantly plant-based diet to one rich in meat and processed foods is thought to be a factor in rising obesity rates. Studies have proved that people with better socioeconomic status are more likely to be obese as they have the adequate resources to be spent on food consumption.

Affordability is a major concern for a huge chunk of the population due to the absence of health insurance and government support policies that cover obesity treatment in developing countries. A major barrier limiting the obesity management industry is the lack of social health insurance and the exclusionary supply of private health insurance plans. Big players can offer certain insurance policies that will cover a big chunk of expenses, and this will also help in attracting more patients.

Request For Customization@https://www.persistencemarketresearch.com/request-customization/33086

Expansion of the overweight treatment market is reliant upon strategic acquisitions and merger activities between market competitors, higher preference for target GLP-1 molecules while developing drug therapies, adoption of telehealth for obesity care, and the emergence of targeted and combination treatment options.

Key Companies Profiled -
Novo Nordisk A/S
VIVUS LLC
AstraZeneca
Currax Pharmaceuticals LLC
Spansules Pharmatech Pvt Ltd
Atkins Nutritional Inc
Apollo Endosurgery, Inc
Herbalife Nutrition Ltd.
SMP Nutra
Allurion Technologies
ReShape Lifesciences, Inc
Bariatric Solutions GmbH
Silimed
ENDALIS
Districlass Medical
Medtronic.

Key Takeaways from Market Study

By treatment, supplements held 89.5% market value share in 2021, and are expected to display a CAGR of 8.1% over the forecast period.

By distribution channel, institutional sales are gaining higher traction for overweight treatment, and held a market value share of 58.2% in 2021.

North America is slated to be the leading regional market for overweight treatment with a projected value share of around 35.2%.

"High incidence of morbid obesity and rising efforts to mitigate indications associated with overweight are driving sales in the overweight treatment market," says an analyst of Persistence Market Research.

Market Competition

Acquisitions, expansion activities, fast-track of FDA approvals, and new product launches are key strategies being adopted by market players to increase their consumer base across geographies and establish a strong market foothold.

In June 2021, the US Food and Drug Administration (FDA) approved Wegovy (semaglutide 2.4mg injection), a Novo Nordisk product for the purpose of chronic weight management.
Apollo Endosurgery received FDA approval for its device Orbera(R) Intragastric Balloon, beneficial for patients with Nonalcoholic fatty liver disease, in March 2021.
In March 2020, VIVUS launched different telemedicine and remote monitoring modules for efficient patient care for health conditions such as obesity.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the overweight treatment market in its latest study, presenting a historical demand assessment of 2017 - 2021 and projections for 2022 - 2032.

Buy Now@https://www.persistencemarketresearch.com/checkout/33086

The research study is based on treatment (drug treatment [bupropion and naltrexone, orlistat, phentermine and topiramate, liraglutide, and others], supplements, medical devices/implants [gastric balloons, gastric bands and stapling devices]) and distribution channel (institutional sales [hospitals, speciality clinics, ambulatory surgical centers], retail sales [retail pharmacies, drug stores, supermarkets/hypermarkets, and health & beauty stores], and online sales), across seven key regions of the world.

Persistence Market Research's Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.

Related Reports-

Diagnostic Imaging Devices Market- https://www.persistencemarketresearch.com/market-research/diagnostic-imaging-devices-market.asp

Proton Therapy Systems Market- https://www.persistencemarketresearch.com/market-research/proton-therapy-systems-market.asp

Media Contact:

Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Overweight Treatment is predicted to reach a market value of US$ 75.1 Bn by 2032|Key Players- Novo Nordisk A/S, VIVUS LLC and more here

News-ID: 2628973 • Views:

More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health Trends
Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Plant-Based Demand
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenience & Demand
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Market Research
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that

All 5 Releases


More Releases for Overweight

Overweight Treatment Market Set for 7.9% CAGR Growth Through 2032, Says Persiste …
The global overweight treatment market is experiencing a significant upswing, driven by a convergence of healthcare challenges and rising public awareness about the health risks associated with obesity. As of 2021, the market was valued at US$ 32.8 Bn, and according to Persistence Market Research, it is expected to grow at a CAGR of 7.9%, reaching US$ 75.1 Bn by 2032. The surge in obesity rates worldwide-now classified as a
Global Overweight Treatment Market Professional Survey Report 2022-2032 Analysis …
The global Overweight Treatment Market is estimated to reach US$ 75.1 Bn at a CAGR of 7.9% by the year 2032. With remote monitoring comes remote surgery. With digital twinning, this surgery becomes feasible. This could help in saving on prices of development of complex medical products, thereby improvising on the time-to-market metric. This would be the thing with the healthcare vertical in the upcoming period. The overweight treatment market is
Overweight Treatment Market: Worldwide Demand, Growth Potential & Opportunity Ou …
The global Overweight Treatment Market is estimated to reach US$ 75.1 Bn at a CAGR of 7.9% by the year 2032. With remote monitoring comes remote surgery. With digital twinning, this surgery becomes feasible. This could help in saving on prices of development of complex medical products, thereby improvising on the time-to-market metric. This would be the thing with the healthcare vertical in the upcoming period. The overweight treatment market is
Overweight Treatment Market is anticipated to top a Revenues of nearly USD$ 75.1 …
Overweight Treatment Market 2022 The global overweight treatment market was valued at US$ 32.8 Bn in 2021. Sales of overweight treatment products are set to witness a high compound annual growth rate of 7.9% and be valued at US$ 75.1 Bn by 2032.  Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/33086 The overweight treatment market is beginning to take hold across the globe with rising number of investments toward various treatment options. According
Overweight Treatment Market To Expand Based On Agile Supply Chains At A CAGR Of …
The global Overweight Treatment Market is expected to witness a CAGR of 7.9% and reach US$ 75.1 Bn by the year 2032. With the way in which healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be healthcare industry's situation
Widening Pool of Obese and Overweight Population Drives Demand for Low-calorie F …
The alarming rise in the cases of obesity and overweight conditions has become a major concern for the majority of governments and health organizations worldwide. These conditions pose a great risk to human life and can potentially give birth to other health related problems too. According to a study by the World Health Organization (WHO), overweight conditions and obesity in people have ended up in about 7–41 percent of certain